Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Sorin J Brener

Showing results (1-10 of 197) with videos related to

Pageof 20
Sort By:
Journal of the American College of Cardiology|November 26, 2016
Should We Measure Biomarkers for Myonecrosis Before and After PCI?Sorin J Brener
Atherosclerosis|January 27, 2017
Beware of calcium, but respect the narrowingSorin J Brener
Circulation. Cardiovascular Interventions|December 21, 2021
What Happened to the Cycle of Knowledge?Sorin J Brener
Journal of the American College of Cardiology|July 16, 2021
Refinements in Predicting In-Hospital Mortality Following PCI: The Science and Art of Competing Risk AnalysisSorin J Brener
The Journal of Invasive Cardiology|January 6, 2010
Measuring the right compound at the right time is not always easySorin J Brener
JACC. Cardiovascular Interventions|March 16, 2020
At the Intersection of Logic and Statistics: Is Proximal Left Anterior Descending Artery Revascularization Still a Notable Event?Sorin J Brener
JACC. Cardiovascular Interventions|June 23, 2018
Whose Urgency Is it, Anyway?Sorin J Brener
JACC. Cardiovascular Interventions|December 21, 2013
Reply: relationship between myocardial reperfusion, infarct size, and mortalitySorin J Brener
Journal of the American College of Cardiology|May 2, 2009
The benefits of platelet glycoprotein IIb/IIIa receptor inhibition during primary percutaneous coronary intervention for ST-segment elevation myocardial infarction: drug-specific or class effect?Sorin J Brener
JACC. Cardiovascular Interventions|March 24, 2017
More Bad News for Patients With Diabetes and a Thin Silver LiningSorin J Brener
Pageof 20

Showing results (1-10 of 197) with videos related to

Sort By:
Pageof 20
Journal of the American College of Cardiology|November 26, 2016
Should We Measure Biomarkers for Myonecrosis Before and After PCI?Sorin J Brener
Atherosclerosis|January 27, 2017
Beware of calcium, but respect the narrowingSorin J Brener
Circulation. Cardiovascular Interventions|December 21, 2021
What Happened to the Cycle of Knowledge?Sorin J Brener
Journal of the American College of Cardiology|July 16, 2021
Refinements in Predicting In-Hospital Mortality Following PCI: The Science and Art of Competing Risk AnalysisSorin J Brener
The Journal of Invasive Cardiology|January 6, 2010
Measuring the right compound at the right time is not always easySorin J Brener
JACC. Cardiovascular Interventions|March 16, 2020
At the Intersection of Logic and Statistics: Is Proximal Left Anterior Descending Artery Revascularization Still a Notable Event?Sorin J Brener
JACC. Cardiovascular Interventions|June 23, 2018
Whose Urgency Is it, Anyway?Sorin J Brener
JACC. Cardiovascular Interventions|December 21, 2013
Reply: relationship between myocardial reperfusion, infarct size, and mortalitySorin J Brener
Journal of the American College of Cardiology|May 2, 2009
The benefits of platelet glycoprotein IIb/IIIa receptor inhibition during primary percutaneous coronary intervention for ST-segment elevation myocardial infarction: drug-specific or class effect?Sorin J Brener
JACC. Cardiovascular Interventions|March 24, 2017
More Bad News for Patients With Diabetes and a Thin Silver LiningSorin J Brener
Pageof 20